The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

March 2021

Medical benefit specialty drug prior authorization list changing in April for most members

Starting in April 2021, we’re adding prior authorization requirements for some drugs covered under the medical benefit. Providers must request prior authorization through AIM Specialty Health®.

For dates of service on or after April 15, 2021, the following drug will require prior authorization for UAW Retiree Medical Benefits Trust PPO non-Medicare members:

  • Kanjinti™ (trastuzumab‑anns), HCPCS code Q5117

For dates of service on or after April 22, 2021, the following drugs will require prior authorization for Blue Cross Blue Shield of Michigan commercial fully insured members and for Blue Care Network commercial, Medicare Plus Blue℠ and BCN Advantage℠ members:

  • Danyelza® (naxitamab‑gqgk), HCPCS codes J3490, J3590, J9999, C9399
  • Margenza™ (margetuximab‑cmkb), HCPCS codes J3490, J3590, J9999, C9399

These requirements don’t apply to members of the Blue Cross and Blue Shield Federal Employee Program® and MESSA.

Submit authorization requests to AIM through the AIM provider portal** or by calling the AIM Contact Center at 1‑844‑377‑1278.

For information about registering for and accessing the AIM ProviderPortal, see the Frequently Asked Questions page** on the AIM website.

More about the authorization requirements

Authorization isn’t a guarantee of payment. Health care practitioners need to verify eligibility and benefits for members.

For more information on requirements related to drugs covered under the medical benefit, see:

We’ll update these lists to reflect these changes prior to the effective dates.

**Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2020 American Medical Association. All rights reserved.